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GASTRIC DYSFUNCTION
IN DIALYSED PATIENTS WITH CHRONIC RENAL FAILURE
Abstract: Gastric dysfunction in dialysed patients with chronic renal failure.
Background: Gastric motor functions are disturbed in patients with chronic renal failure (CRF). 
The aim of this study was to fi nd the relationship between GI symptoms, gastric myoelectrical 
activity and regulatory peptides (gastrin, motilin, VIP, CCK) in patients with CRF treated with 
hemodialyses (HD) and peritoneal dialyses (CAPD). 
 Me thods: Gastric myoelectric activity was evaluated with cutaneously recorded electro-
gastrographs (EGGs) measurement in: group A: 23 pts with CRF treated with CAPD, group B: 
21 pts treated with HD and group C: 48 matched healthy controls. GI symptoms severity was 
quantifi ed with specially designed questionnaire. The laboratory evaluation of plasma parameters, 
such as: gastrin, motilin, VIP and CCK was performed.
 Resu l t s: The patients with CRF treated with CAPD and HD showed a signifi cantly lower 
percentage of normal 2–4 cpm wave’s rhythm in both fasting (65.3 ± 29.3% vs 43.5 ± 35.9% vs 
86.4 ± 10.2%) and fed conditions (72.7 ± 34.2% vs 69.5 ± 22.1% vs 89.3 ± 9.5%) in comparison 
to controls. In the fasting state, none of the healthy controls had an abnormal EGG, whereas 
the 27 patients with CRF (61.3%) had an abnormal EGG. In the fed state the 18 patients with 
CRF (40.9%). No signifi cant increase of the dominant power (PDP) after meal in CRF patients 
was observed. The plasma concentrations of gastrin, CCK were increased in fasted and fed CRF 
patients, whereas VIP and motilin only in fed state.
 Conc lus i ons: The patients with CRF showed impaired gastric myoelectrical activity in 
response to food and high levels of GI hormones. Gastric dysmotility and high peptides appears 
to be partially responsible for GI symptoms.
Key words: gastrointestinal symptoms, gastric myoelectrical activity, gastrointestinal hormones, 
chronic renal disease
40
INTRODUCTION
Gastrointestinal (GI) symptoms, like nausea, anorexia, bloating and early 
satiety are common in patients with chronic renal failure (CRF). They could 
induce malnutrition which is common in dialysed patients. Various nervous 
and hormonal factors may contribute to the development of these symptoms, 
but the underlying mechanisms have not been elucidated. A considerable 
number of circulating hormones and peptides and neural pathways have been 
implicated in these pathways. The kidney is a major site for the inactivation, 
degradation, and clearance of a variety of peptide hormones. It has been shown 
that the uremia increases or decreases GI hormones levels. Fasting plasma 
concentrations of gastrin-releasing peptide, motilin, neurotensin, pancreatic 
polypeptide, peptide YY, somatostatin, substance P, and vasoactive intestinal 
peptide (VIP) were increased in chronic renal failure CRF [1]. Postprandial 
released gastrin — from gastric antrum — not only has a stimulatory effect on 
gastric acid secretion, but also on smooth muscle through muscarinic (mainly 
M3) receptors by acting on the cholinergic component of the gastric nervous 
plexus. Soffer et al. [2] found delayed gastric emptying in dialysed patients; this 
led to the hypothesis that dyspeptic symptoms, occurring in dialysed patients, 
are possibly a consequence of impaired gastric motility and subsequently 
disturbed emptying [3, 4]. Measuring of gastric emptying has been widely 
accepted as a method of investigating gastric motility, but this measurement 
only refl ects postprandial gastric motor status. Gastric myoelectrical activity 
recording provides information about both — fasting, as well as fed gastric 
motor function. There are some reports [5–7] concerning impaired gastric 
myoelectrical activity induced delayed gastric emptying in renal failure patients, 
but most of these studies did not distinguish the patients treated with dialysis 
from those treated conservatively. On the other hand, there are few reports of 
simultaneous evaluations of gastric myoelectrical activity and gastric emptying 
that would allow comparison of the respective symptoms with fi ndings observed 
during the measurements of gastric dysmotility [8–11]. 
It is well known that cutaneous electrogastrography (EGG) undergoes 
a change after food ingestion, showing increases in frequency and amplitude 
compared with preprandial values, but the factors regulating such changes 
remain to be controversial. Paying special attention to gastrin, motilin and 
CCK, VIP — the two pair’s postprandial and interdigestive motility peptides, 
we investigated the relationship between gastric myoelectrical activity and GI 
motility peptides and symptoms that occurred in patients with CRF.
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MATERIAL AND METHODS
The study was performed on 48 asymptomatic normal subjects with no history 
of renal disease or GI disease and 44 symptomatic patients with CRF who were 
diagnosed by clinical and laboratory measures. Into the study 92 persons were 
involved, which were divided into three subgroups: 
— Group A — 23 pts (14 M, 9 F, age 63 ± 14 years (36–81 yrs)) with chronic 
renal failure (CRF) treated with continuous ambulatory peritoneal dialysis 
(CAPD).
— Group B — 21 pts (13 M, 8 F, age 63 ± 12 (37–79 yrs)) with CRF treated 
with hemodialysis (HD).
— Group C — 48 healthy volunteers (13 M, 35 F, age 63 ± 12 (27–64 yrs)). 
In this study the exclusion criteria were: diabetes mellitus, obesity (BMI ≥ 30 
kg/m2), cardiovascular diseases (hypertension, coronary artery disease, valvular 
heart disease, cardiac arrhythmias), not smoking cigarettes at present or 
Table  1
Characteristics of the investigated subjects
p < 0.05 statistical signifi cant; * signifi cant differences between group A and B, 
# — between group A and C; & — between group B and C; Group A — with chronic renal 
failure (CRF) treated with the continuous ambulatory peritoneal dialysis (CAPD); 
Group B — with CRF treated with the hemodialysis (HD); Group C — control group. 
BMI — body mass index, HR — heart rate, BPs — systolic blood pressure, 
BPd — diastolic blood pressure, KT/V — urea, nPCR — normalized protein catabolic rate
PARAMETERS GROUP A (N = 23)
GROUP B 
(N = 21)
GROUP C
(N = 48) p
Age [years] 63 ± 14 63 ± 12 50 ± 10 NS
Sex (w/m) 8/7 7/10 6/12 NS
BMI [kg/m2] 26.9 ± 3.5 23.7 ± 2.1 23.8 ± 0.6 NS
HR (bit/min) 77.3 ± 12.4 75.5 ± 11.6 69.1 ± 11.1 0.03#&
BPs 120 ± 8.3 127 ± 9 126.5 ± 9 NS
BPd 80 ± 6 88 ± 8 84 ± 9 NS
CRF Time (months) 83.2 ± 57.3 134.9 ± 108.9 …………… 0.04*
Creatinin umol/l 1840 ± 3120 49.5 ± 70 80.1 ± 4.4 0.001*#&
KT/V 2.15 ± 2.15 1.49 ± 0.14 …………… NS
ALBUMIN 35.1 ± 5.4 36.0 ± 3.9 58.7 ± 4.2 NS
nPCR 0.94 ± 0.24 …………… …………… NS
TRANSFERRIN g/l 1.96 ± 0.50 1.55 ± 0.33 3.1 ± 0.5 0.04#&
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during 3 last months, medications that may interfere with gastric myoelectric 
measurements, previous surgeries, as well as any pathologies in the GI tract 
(eg, infl ammatory bowel disease), gynecological systems, or chronic diseases.
The following parameters were determined for characteristics of the inves-
tigated subjects:
(1) Dialysis adequacy in patients: urea KT/V (a multiple of the volume of 
plasma cleared of urea divided by the distribution volume of urea) and nPCR 
(normalized protein catabolic rate) [12, 13].
(2) Long-term nutritional markers: plasma creatinine, albumin, and trans-
ferrin. Body mass index (weight in kg/height2 in meters) was the nutritional 
anthropometric method used to evaluate severe obesity (BMI > 30) (Tab. 1).
The  s tudy  p ro toco l
All subjects were fasted for 6 hr or more prior to the study and had taken no 
medications with a known effect on GI motility during three days before the 
study. 
In all of investigated subjects were performed the following tests: assessment 
of GI symptoms, gastric myoelectric activity in the preprandial period and 
postprandial period after standard meal, and plasma gastrin, CCK, VIP, motilin 
measurements before and after standard meal.
The study protocol was approved by the Jagiellonian University Bioethical 
Committee (no. KBET/11/B/2004). All the subjects included in this study 
were instructed about its purpose and gave/submitted their written consent 
of participation.
Assessment  o f  G I  s ymptoms
All patients completed a self-administered questionnaire that included eight 
symptoms (heartburn, abdominal pain, belching, regurgitation, nausea, 
vomiting, dysphagia, bloating) to assess subjective GI symptoms. The severity 
of each of these symptoms was scored as: absent (0), mild (1), moderate (2), or 
severe (3). Factor analyses were also performed.
E l ec t rogas t rog raphy  (EGG)
Surface electrogastrography was applied to record gastric myoelectrical activity 
measured in the preprandial period (30 min) and postprandial period (60 min) 
after standard meal (Nutridrink 300 kcal, Nutricia, Poland). Gastric myo electrical 
activity was recorded with three Ag-AgCl standard cutaneous electrodes. One 
electrode (electrode 1) was placed at the midpoint between the xiphoid and the 
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navel; one (electrode 2) was placed 5 cm to the left and 3 cm above this point; 
and a reference electrode (electrode 0) was placed in the lower quadrant close 
to the left costal margin. The bipolar EGG signal was derived from electrodes 
1 and 2 and was amplifi ed using a portable EGG recorder (Digitrapper EGG, 
Synectics Medical, Inc., Irving, Texas) with low and high cutoff frequencies of 
1 and 18 cpm, respectively. Online digitization with a sampling frequency of 
1 Hz was performed using an analog-digital converter installed on the recorder, 
and digitized samples were stored using the adjuvant software (Synectics Medi-
cal AB, Stockholm, Sweden). In the analysis of EGG the following parameters 
were evaluated: percentage of dysrhythmia time (0.5–2 cpm — bradygastria; 
4–10 cpm — tachygastria), percentage of normogastria (2–4 cpm), dominant 
frequency (PDF); dominant power of dominant frequency (PDP). PDF — Period 
Dominant Frequency was calculated as the average of the dominant frequen-
cies (highest peak) of FFT (Fast Fourier Transform) line. PDP — Period Domi-
nant Power is the power or amplitude of the PDF peak. Changes in the EGG 
dominant power appear to refl ect gastric contractility [14–16].
B i ochemica l  a ssays
The levels of gastrin, VIP, motilin and CCK were measured before and after 
standard meal. Blood samples were stored in the 2–8˚C and within 2 hours after 
blood collection were centrifuged to separate the plasma (at 3800 g, at 8˚C for 
10 minutes). The supernatant was aspirated and stored in the 20˚C for a period 
of 6 hours up to 1 month until the time of analysis. The assessment of the plasma 
gastrin level was performed by using Gastrin I (G 17), (R&D Systems Inc., USA, 
sensitivity of test 0.7 ng/ml) for automated systems. Analysis of plasma VIP 
concentration was performed by using Human Vasoactive Intestinal Peptide 
(VIP) kit (Phoenix Pharmaceuticals INC, USA, sensitivity of test 0.13 ng/ml) for 
automated systems. Analysis of plasma CCK levels was performed by using 
Bender MedSystems test — (Bender MedSystems, Austria, sensitivity of test 
1.65 ng/ml) for automated systems. Analysis of plasma motilin concentration 
was performed by using RIA test.
S ta t i s t i ca l  ana l ys i s
Database management and statistical analyses were performed using the 
Statistica for the Windows, version 7.0 PL (StatSoft the Inc., the Tulusa, 
Oklahoma, USA). All values are expressed as either percentages or mean 
± SD. The non-normal distribution of the obtained data was demonstrated 
by Shapiro-Wilk’s test. In the case of non-fulfi lled criteria of normality, the 
variables underwent a logarithmic transformation that was then used in the 
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further statistical analyses. Comparisons between investigated groups for 
quantitative variables were calculated by using unpaired Student’s T-test or 
Wilcoxon’s signed rank test if either distribution was not normal. Statistical 
analysis of the feeding influences was performed using paired Student’s 
T-test or Mann-Whitney’s U test. Associations between the measures of EGG 
parameters, enterohormons and GI symptoms were studied with the Spearman’s 
correlation coefficients. Statistical significance was assigned for p values 
of < 0.05.
RESULTS
E lec t rogas t rog raphy  (EGG)
There were observed significant changes of gastric myoelectric activity in 
patients with CRF (Tab. 2). The patients with CRF being treated with CAPD and 
HD showed a signifi cantly lower percentage of normal 2–4 cpm wave’s rhythm 
in both — fasting and fed — states in comparison to the healthy controls. The 
healthy controls had a mean percentage of 2–4 cpm waves of 86.4 ± 10.2% in 
the fasting state and 89.63 ± 9.5% in the fed state. In contrast, the patients 
treated with CAPD and HD had in the fasting state a mean percentage of 2–4 
cpm waves of 65.3 ± 29.3% vs 43.5 ± 35.9% and in the fed state 75.7 ± 34.2% 
vs 69.5 ± 22.1% respectively. There was, however, no difference between the 
two groups of patients in fasting state, although different responses of the 
power of the EGG at the dominant frequency (PDP) period of dominant power 
(μV) among the three subject groups were observed. As shown in Table 2, the 
healthy controls had an average increase from 5.2 ± 1.1 to 6.1 ± 1.4 in the 
dominant power of the EGG after meal, whereas the patients from groups A 
and B had no signifi cant increase. Fasted values of PDP remained higher in 
both patients group — A and B — than those observed in control — group C; 
7.2 ± 1.5 and 6.2 ± 2.6 vs 5.2 ± 1.1. A power ratio of < 1 is believed to correlate 
with a decreased distal gastric motor response to a meal. In our previous studies, 
the response of the EGG to a test meal was defi ned as abnormal if there was 
no increase in the dominant power of the EGG [14]. Using this defi nition, it 
was found that none of the controls (0%) had an abnormal response to the 
test meal, whereas 6 of the patients with CRF in group A (26%) and 9 of 
the patients of group B (42.9%) had an abnormal power response to the test 
meal (p < 0.01 in comparison to the controls). The prevalence of an abnormal 
response of the EGG to the test meal was signifi cantly higher in the patients 
with CRF than those without (p < 0.05). Figure 1 presents percent changes 
of EGG parameters in response to standard’s meal in all investigated groups. 
It can be seen that the EGG in the healthy subject had more regular 3 cpm 
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slow waves than that in the both patients’ group. The spectra period dominant 
frequency (PDF) confi rmed this observation.
In groups A and B values of PDF (cpm/min) in fasted and fed patients were 
lower than those observed in the healthy individuals — C group; 2.0 ± 1.2 
and 1.8 ± 1.4 vs 2.7 ± 0.6 [cpm/min] respectively, p = 0.001 and 1.5 ± 1.3 
and 1.3 ± 1.3 vs 2.7 ± 0.5% [cpm/min] respectively, p = 0.004. In previous 
reports [8], an EGG was defi ned as abnormal if the percentage of 2–4 cpm 
slow waves was below 70%. Using this defi nition, we found that there was a 
signifi cantly higher prevalence of the abnormal EGG in the patients with CRF 
than in healthy controls. In the fasting state, none of the healthy controls had 
an abnormal EGG, whereas 20 patients with CRF (45.5%) had an abnormal 
EGG: in group A 8 patients (34.8%) and in group B 12 patients (57.1%). In 
the fed state, all healthy subjects had a normal EGG, whereas 6 patients with 
CRF (26%), in group A, had an abnormal EGG (p = 0.005 in comparison to the 
controls), and 8 patients with CRF (38.1%), in group B, had an abnormal EGG 
(p = 0.002 in comparison to the controls). However, there was no signifi cant 
Table  2
The electrogastrography parameters in all investigated groups before and after standard meal
p < 0.05 statistically signifi cant; * signifi cant differences between group A and B, 
# — between group A and C; & — between group B and C; 
Group A — with CRF treated with the continuous ambulatory peritoneal dialysis (CAPD); 
Group B — with CRF treated with the hemodialysis (HD); Group C — control group;
0.5–2 cpm — bradygastria, 2–4 cpm — normogastria, 4–10 cpm — tachygastria,
PDF — period dominant frequency, PDP — period dominant power
EGG Group A Group B Group C p
PR
E
PR
A
N
D
IA
L
0.5–2 [cpm] 9.9 ± 17.5# 4.1 ± 5.1& 9.2 ± 10.1 0.01&
2–4 [cpm] 65.3 ± 29.3 43.5 ± 35.9 86.4 ± 10.2 0.01#/0.001&
4–10 [cpm] 8.6 ± 13.8 16.4 ± 28.8 4.3 ± 8.1 NS
Dysrhythmias 24.5 ± 23.1 38.5 ± 33.9& 13.5 ± 10.2 0.008&
PDF [cpm/min] 2.0 ± 1.2# 1.8 ± 1.4& 2.7 ± 0.6 0.06#/0.03&
PDP μV2 7.2 ± 1.5# 6.2 ± 2.6 5.2 ± 1.1 0.005#
PO
ST
PR
A
N
D
IA
L
0.5–2 [cpm] 4.8 ± 8.8 5.9 ± 8.1 6.2 ± 8.4 NS
2–4 [cpm] 72.7 ± 34.2 69.5 ± 22.1& 89.3 ± 9.5 0.003&
4–10 [cpm] 12.2 ± 19.0 9.7 ± 12.3 10.6 ± 9.4 NS
Dysrhythmias 15.7 ± 26.6 20.1 ± 16.9& 4.5 ± 5.5 0.04&
PDF[cpm/min] 1.5 ± 1.3# 1.3 ± 1.3& 2.7 ± 0.5 0.004#/0.0004&
PDP μV2 7.1 ± 1.4# 6.7 ± 2.4 6.1 ± 1.4 0.07#
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difference in the prevalence of the abnormal EGG between the two patients’ 
groups, in either fasting or fed state. There was no difference in the percentage 
of tachygastria between the patients with CRF and healthy group, in both 
— the fasting and fed state.
 
Fig. 1. Percent changes of electrogastrography parameters in response to standard meal 
in all investigated groups
* — p < 0.05; Group A — with CRF treated with the continuous ambulatory peritoneal dialysis 
(CAPD); Group B — with CRF treated with the hemodialysis (HD); Group C — control group; 
0.5–2 cpm — bradygastria, 2–4 cpm — normogastria, 4–10 cpm — tachygastria, PDF — period 
dominant frequency, PDP — period dominant power
G I  pep t ides
The fasting plasma levels of four chosen GI regulatory peptides (gastrin, CCK, 
VIP, motilin) were measured by radioimmunoassay in 44 stable patients with 
CRF receiving peritoneal or hemodialysis treatment regularly and compared to 
those of 48 healthy matched controls. The plasma concentrations of gastrin, 
CCK, VIP and motilin were increased in fasted and fed CRF patients and were 
higher than control, except VIP and motilin in fasting state (Tab. 3).
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The level of plasma gastrin
The fasting plasma level of gastrin was higher in group A and B than in the 
group C (6.57 ± 2.37 vs 4.2 ± 1.6 vs 1.2 ± 0.5 [pg/mL] respectively, p = 0.001; 
Tab. 3). After meal there was noted signifi cant increase in group B and C 
(Fig. 2).
The level of plasma CCK
The fasting plasma level of CCK was signifi cantly higher in group A and B 
than in the group C (11.6 ± 9.2 vs 8.1 ± 4.9 vs 3.0 ± 1.5 [pg/mL] respectively, 
p = 0.001; Tab. 3). After meal signifi cant increase in group A and C was 
observed (Fig. 2).
The plasma level of VIP
The fasting plasma level of VIP was signifi cantly higher in group B than in the 
group A and C (35.0 ± 18.9 vs 18.2 ± 4.3 vs 26.3 ± 1.9 [pg/mL] respectively, 
p = 0.006; Tab. 3). After meal signifi cant increase in group A and C was found 
(Fig. 2).
Table  3
Levels of GI hormones in all investigated group
p < 0.05 statistically signifi cant; * signifi cant differences between group A and B, 
# — between group A and C; & — between group B and C; 
Group A — with CRF treated with the continuous ambulatory peritoneal dialysis (CAPD); 
Group B — with CRF treated with the hemodialysis (HD); Group C — control group; 
VIP — Vasoactive Intestinal Peptide, CCK — cholecystokinin
Group A Group B Group C p
PR
E
D
PR
A
N
-
D
IA
L
Gastrin 6.57 ± 2.37 4.2 ± 1.6 1.2 ± 0.5 0.001*#&
CCK 11.6 ± 9.2 8.1 ± 4.9 3.0 ± 1.5 0.01#/0.001&
VIP 18.2 ± 4.3 35.0 ± 18.9 26.3 ± 1.9 0.006*/0.0001#
Motilin 197.7 ± 72.3 158.1 ± 87.4 164.0 ± 99.6 NS
PO
ST
PR
A
N
-
D
IA
L
Gastrin 7.0 ± 2.9 4.71 ± 1.9 1.58 ± 0.7 0.001*#&
CCK 12.7 ± 10.0 8.1 ± 4.9 3.5 ± 1.5 0.01#/0.003&
VIP 25.1 ± 6.8 35.1 ± 12.1 27.9 ± 6.5 0.01*
Motilin 316.0 ± 218.9 212.9 ± 107.1 142.0 ± 79.2 0.02#/0.02&
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The plasma level of motilin
The fasting plasma level of motilin was signifi cant higher in group A than in 
the group B and C (197.7 ± 72.3 vs 158.1 ± 87.4 vs 164.0 ± 99.6 [pg/mL] 
respectively, p = 0.001; Tab. 3). After meal signifi cant increase in group A 
and B was recorded, but in group C plasma level of motilin was decreased 
(Fig. 2).
 
Fig. 2. Percent changes of gastrointestinal hormones in response to standard meal 
in all investigated groups
* — signifi cant differences between fast and fed state (p < 0.05);
Group A — with CRF treated with the continuous ambulatory peritoneal dialysis (CAPD);
Group B — with CRF treated with the hemodialysis (HD); Group C — control group;
VIP — Vasoactive Intestinal Peptide, CCK — cholecystokinin
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GI  symptoms
Symptoms’ Score
Eight symptoms were scored, including; heartburn, abdominal pain, regur-
gitation, belching, nausea, vomiting, dysphagia and bloating — each graded 
from 0 to 3, with 0 meaning: no symptoms and 3: the most severe. A total 
symptoms’ score was calculated for each patient, and then an average of to-
tal symptoms’ score for each group of subjects was computed. The average 
of  total symptoms’ score was 0 for the healthy controls, 6 ± 2 for the patients 
with CRF in group A, and 4 ± 1 for the patients with CRF in group B. There 
was observed a signifi cant difference in the symptoms’ score between the con-
trols and patients, but no signifi cant difference between the two groups of 
patients with CRF.
Correlation
Symptoms vs EGG. The GI symptoms (belching, nausea, vomiting) were inversely 
correlated with the dominant power (PDP) (r = –0.67; p = 0.03) in the CAPD 
treated patients group and positively correlated with tachygastria (r = 0.78; 
p = 0.03), bradygastria (r = 0.78; p = 0.03) and dysrhythmia in pre- (r = 0.89; 
p = 0.006) and postprandial (r = 0.77; p = 0.03) period in the HD treated 
patient group.
Symptoms vs enterohormones. In the group of patients treated with CAPD, 
the nausea negatively correlated with preprandial gastrin (r = –0.89; p = 0.04) 
and positively with VIP (r = 0.89; p = 0.04). We noted a positive correlation 
between belching, nausea and postprandial VIP level (r = 0.74; p = 0.02) and 
between belching and preprandial gastrin (r = 0.9; p = 0.004) in the HD treated 
group.
EGG vs hormones. In the group of patients treated with HD, the plasma 
VIP level was inversely correlated with preprandial PDP (r = –0.5; p = 0.04) 
and positively VIP with normogastria (r = 0.54; p = 0.02) and motilin with 
preprandial PDP (r = 0.5; p = 0.04). Postprandial CCK was positively correlated 
with bradygastria (r = 0.66; p = 0.004). In CRF group with CAPD we observed 
positive correlation between postprandial plasma CCK level (r = 0.55; p = 0.04), 
motilin level and dysrhythmia (r = 0.62; p = 0.01) and negative correlation 
between preprandial CCK and tachygastria (r = –0.55; p = 0.03) and between 
preprandial VIP plasma level and PDF (r = –0.6; p = 0.02).
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DISCUSSION
This study was undertaken to evaluate the pathophysiological importance of 
changes in gastric myoelectric activity and peptides levels in hemodialysed and 
peritoneodialysed CRF patients. We have found that: 
(1) Patients with CRF showed a signifi cantly lower percentage of normal 
2–4 cpm waves in both fasting and fed states. There was a signifi cantly higher 
prevalence of the abnormal EGG (the percentage of normogastria below 70%) 
in the patients with CRF in both fasting and fed states. 
(2) In comparison to healthy controls, the EGG parameters obtained from 
patients with CRF showed higher values than in control and there wasn’t also 
observed any increase in the amplitude of the EGG after the test meal. The 
prevalence of an abnormal response of the EGG to the test meal (no increase or 
a decrease in EGG dominant power after the test meal) was signifi cantly higher 
in patients with CRF. 
(3) There was a significant increase in the dominant frequency in the 
controls after the test meal; but such a phenomenon was not observed in 
patients with CRF. 
(4) There was no signifi cant difference in the regularity of the gastric slow 
wave between the patients treated with CAPD and those treated with HD. The 
prevalence of an abnormal response to the test meal in EGG dominant power 
was signifi cantly higher in the group of patients treated with CAPD than in the 
one treated with HD. 
(5) No signifi cant difference was found in the symptoms’ scores between the 
two groups of patients, although the patients treated with CAPD had a slightly 
higher score. 
(6) The plasma concentrations of gastrin, CCK were increased in fasted and 
fed CRF patients, VIP and motilin only in fed stage. They were higher than 
control.
(7) Correlation between elevated serum enetrohormons levels (gastrin, VIP, 
CCK, motilin), GI symptoms and gastric myoelectrical activity disturbances was 
found.
In this study, we used EGG and evaluation of serum GI peptides levels to 
assess gastric function. Still, there is a lack of data about gastric myoelectrical 
activity and GI peptides in patients with CRF [17–19]. The studies conducted by 
Ravelli et al. [4, 5] were the fi rst experiments investigating gastric myoelectrical 
activity in CRF patients. Their studies were performed in pediatric patients 
with CRF, and gastric myoelectric activity was also recorded using EGG. The 
studied patients were children with severe CRF and symptoms of anorexia and 
vomiting. The majority of patients were having gastric dysrhythmias, including 
both bradyarrhythmia and tachyarrhythmia. However, no quantitative fi gure, 
such as the percentage of 2–4 cpm slow waves was given in that study. Jebink 
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et al. [6], performed a study, where there was recorded gastric myoelectrical 
activity in adult patients with CRF and then analyzed using a more quantitative 
method. The consistency between this current study and the previous studies 
by Ravelli et al. suggests that noninvasive EGG is a reliable technique for the 
measurement of gastric myoelectric activity.
In our study, all patients suffered from end-stage renal disease with severe 
uremia and were treated with using CAPD or HD. Furthermore, our study is 
the fi rst to simultaneously measure gastric myoelectric activity and serum GI 
hormones’ levels in patients with CRF. We found that in CRF patients there 
occurred a specifi c pattern of gastric hypomotility, including disturbed gastric 
myoelectrical activity and increased GI hormones, compared to healthy con-
trols. In addition, a signifi cant correlation was observed between certain EGG 
parameters and GI hormones, as well as GI symptoms. Gastric myoelectrical 
activity is an essential trigger for predicting gastric emptying and contractil-
ity. Chen et al. [8, 9] showed that postprandial gastric dysrhythmia predicted 
delayed gastric emptying, while abnormality in the postprandial EGG power 
predicted delayed gastric emptying with an accuracy of more than 70%. Other 
studies [20, 21] showed that disturbance of the postprandial increase in the 
EGG power refl ected gastric hypocontraction. These studies support our results.
The EGG patterns in healthy subjects usually show specifi c responses to 
a test meal [11]. These include both, a substantial increase in the amplitude 
or dominant power and a significant increase in the dominant frequency 
of the EGG test after a meal. These phenomena were also observed in the 
normal subjects in our study. However, the fasted dominant power of the EGG 
was higher in both patients’ groups with CRF than in control group. After 
a meal, PDP increased, although — it was not as substantial as reported in the 
control [6].
Several studies have suggested the importance of tachygastria in the gene-
sis of dyspeptic symptoms, including nausea and bloating [22, 23]. In Chen 
at al. studies, the lower percentage of normogastria and a smaller increase/
decrease in the PDP of fed pattern indicated the myoelectrical gastroparetic 
response [24, 25]. Using such defi nition based on those results, he showed that 
described disturbances in fed pattern may predict delayed gastric emptying 
with an accuracy of 78%. That is, according to those data, that a majority of 
patients with an abnormal postprandial EGG or an abnormal response to the 
test meal have delayed gastric emptying [11]. Based on such conclusion, we 
may interpret our data in a way that we suggest that most of the patients with 
CRF how the pattern of delayed gastric emptying after the meal. And such 
a point of view could be supported with the results of other studies [2, 26–28].
In the present study, there was observed a high prevalence of GI symptoms 
in patients with CRF. We found that patients with both, abnormal EGG and 
high GI hormones levels showed a simple relationship between GI symptoms’ 
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scores and dysrhythmias and inverse correlation between GI symptoms and 
PDP. However, the percentage of tachygastria and bradygastria did not differ 
signifi cantly between CRF patients and controls in postprandial period, while 
the preprandial percentage of bradygastria was higher in CRF patients. Our 
data support previous reports and confi rm that gastric dysmotility might be 
considered as an important etiologic factor of dyspeptic symptoms. 
The kidney is a major site of inactivation of GI polypeptides (e.g, gastrin, 
CCK, neurotensin and pancreatic polypeptide) involved in the modulation of GI 
motility and the regulation of hunger and satiety. Thus, serum levels of several 
hormones are signifi cantly raised as a consequence of renal failure and can be 
reversed to normal by renal transplantation. 
In healthy subjects, the intramuscular injection of tetragastrin signifi cantly 
increased EGG frequency dose-dependently, but caused no signifi cant change 
in amplitude [29]. These results suggest that the increase in endogenous 
gastrin release is one of the mechanisms which underlie the increase in EGG 
frequency after food ingestion. In our studies, despite of high plasma gastrin 
fasting level in CFR patients, food did not signifi cantly alter gastrin release in 
HD patients. Sirinek at al. [1], partially confi rmed our results showing that mean 
serum amylase, lipase, secretin, and gastrin levels were found meaningfully 
decreased according to the beginning values at third months of the CAPD and 
HD treatment. However, they were higher than control group. 
VIP paracrine release is a neuromodulator of the sphincters actions. Its 
infl uences include relaxation of gastric and intestinal smooth muscles and 
inhibition of gastric secretions. In uremic patients, wide variations of plasma 
concentrations of VIP have been reported. Kabemura at al. [30] found that in 
patients treated with HD, the plasma concentrations of the main GI peptides 
increased. In our study, in the group treated with CAPD, VIP level was lower 
than control and had signifi cantly increased after feeding — in contrary to the 
group treated with HD, where it was higher than control. Sharkaway at al., 
found similar to our relationship high difference plasma VIP levels in uremic 
patients where 5 times higher than control [31]. There exists also, inverse 
correlation between VIP levels and manometry. VIP was low in subgroup with 
normal manometry, but its levels were elevated in patients with dysmotility. 
Similarly to our study, VIP levels were elevated in patients with bradygastria 
and tachygastria.
CCK is early satiation’s factor [32]. CCK binds to receptors on vagal afferents 
and mucosa and induces gastric relaxation and slow gastric emptying. CCK is 
metabolized by the kidney [33], consequently its serum levels can be raised 
in renal failure [1]. Given that CCK accumulates in CRF and retards gastric 
emptying [34], it may be partly responsible for the premature satiation effect. 
Degree of elevation was correlated with the severity of renal damage. In our 
study, CCK levels were signifi cantly higher in CRF patients and positively 
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correlated with bradygastria and dysrhythmia, as well as with satiety [35]. 
CCK has recognized anorectic effect, although this direct association might be 
lacking because of an abnormal stimulation of these CCK–glucose feedback 
(trypsin) due to continuous peritoneal not bowel mucosa lavage. This suggests 
that CCK level could be an immediate food intake marker in CAPD patients. 
CRF is the clinical state to be associated with elevated plasma motilin 
concentrations [36–37]. Our study confi rmed previous fi ndings that the fasting 
plasma levels of motilin was signifi cantly higher in patients treated with CAPD 
than those treated with HD and the control, as well as that after meal it had 
further increased. Shima et al. [38] had found that hypermotilinemia and 
the accumulation of this high molecular weight motilin in patients with CRF 
suggest that the kidney plays some role in the elimination of motilin, and 
further, that the clearance of the high molecular motilin is more dependent on 
renal function than that of authentic motilin. 
The above observations indicate that gut hormones’ release, in particular 
response to CCK, is likely to have pathogenetic signifi cance in the GI dysmo-
tility observed in CRF patients [39]. Increased levels of motilin and PYY may 
exacerbate impaired energy intake by slowing gastric emptying in patients in 
whom nutrition is already compromised. 
In summary, this is the fi rst study to evaluate gastric myoelectric activity 
and GI hormones simultaneously in patients with end-stage renal disease 
treated with hemodialyses and peritoneal dialyses. CRF patients showed 
impaired gastric myoelectrical activity suggesting dysmotility and mostly higher 
levels gastrointestinal peptides which may be responsible for dysmotility and 
symptoms. 
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